A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial

BACKGROUND: Pneumococcal conjugate vaccines (PCV) effectively prevent pneumococcal disease but the global impact of pneumococcal vaccination is hampered by the cost of PCV. The relevance and feasibility of trials of reduced dose schedules is greatest in middle- and low-income countries, such as The...

Descripción completa

Detalles Bibliográficos
Autores principales: Mackenzie, Grant A., Osei, Isaac, Salaudeen, Rasheed, Hossain, Ilias, Young, Benjamin, Secka, Ousman, D’Alessandro, Umberto, Palmu, Arto A., Jokinen, Jukka, Hinds, Jason, Flasche, Stefan, Mulholland, Kim, Nguyen, Cattram, Greenwood, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785014/
https://www.ncbi.nlm.nih.gov/pubmed/35073989
http://dx.doi.org/10.1186/s13063-021-05964-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785014/
https://www.ncbi.nlm.nih.gov/pubmed/35073989
http://dx.doi.org/10.1186/s13063-021-05964-5

Ejemplares similares